Late-onset neutropenia in a multiple sclerosis patient after first dose ocrelizumab switched from rituximab

Michael Auer, Gabriel Bsteh, Harald Hegen, Sebastian Wurth, Anne Zinganell, Thomas Berger, Florian Deisenhammer, Franziska Di Pauli